Skip to main content

IE 11 is not supported. For an optimal experience visit our site on another browser.

  • Mysterious disappearance of Alabama woman raising questions

    01:58

  • Now Playing

    FDA approves drug to protect infants from RSV

    01:01

  • UP NEXT

    Long Island police investigating new evidence in Gilgo Beach murders

    02:03

  • Florida insurance crisis worsening as rates skyrocket

    01:54

  • Independent organization launching $70 million effort for third party presidential campaign

    02:01

  • Historic heat wave fueling fires in California, scorching Southwest with triple digit temperatures

    02:19

  • Search intensifying for two children swept away in Pennsylvania flash floods

    01:55

  • New details revealed about how Pennsylvania escaped fugitive was captured

    02:03

  • Sunday marks 78 years since scientists first tested nuclear bomb

    01:34

  • Alabama woman who vanished after reporting seeing toddler alone on highway returns home

    01:58

  • Small plane crash lands in Martha’s Vineyard after pilot suffers medical emergency, police say

    01:34

  • DeSantis fires about a dozen staffers in cost cutting move

    00:41

  • Neighbors surprise 7-year-old, whose mother was battling cancer, with a birthday party

    02:22

  • Doctors weigh in as cases of common cold on the rise this summer

    01:55

  • Heat wave felt coast to coast as triple digit temperatures break records

    01:27

  • Urgent search underway for missing Alabama woman

    02:03

  • Ukraine F-16 fighter pilot training to start next month

    02:33

  • At least 4 people fatally shot by suspect in Georgia, police report

    01:06

  • New details revealed about suspect in Long Island murders

    02:49

  • Hollywood actors join writers on strike, demanding higher pay and AI protections

    01:51

The FDA approved the drug Beyfortus to protect young children against RSV. If the CDC agrees with the FDA’s recommendations, the injections could be available by the fall. NBC News’ Tom Costello has details.

Source

Leave a Reply